Ernexa Therapeutics (ERNA) Earnings Date & Reports

Ernexa Therapeutics Inc is a preclinical-stage synthetic allogeneic iMSC therapy company developing medicines to treat various forms of cancer and other diseases with high unmet medical needs... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

ERNA is expected to report earnings to rise 70.16% to -210 cents per share on August 17

Ernexa Therapeutics ERNA Stock Earnings Reports

Q2'26

Est.

$-2.11

Q4'22

Missed

by $1.10

Q3'22

Missed

by $0.29

Q2'22

Beat

by $0.07

Q1'22

Beat

by $0.04

The last earnings report on March 20 showed earnings per share of -124 cents, missing the estimate of -14 cents. With 18.42K shares outstanding, the current market capitalization sits at 6.90M.

View a ticker or compare two or three

Compare

ERNA

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for ERNA